Skip to main content
NIH funding notice PAS-19-097

Research to Advance HBV Cure: HIV/HBV Co-Infection and HBV Mono-infection (R01 Clinical Trial Not Allowed)

Closed on January 7, 2020.

Posted
November 29, 2018
Close date
January 7, 2020
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

6 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,317,884 in first-year total cost, median $518,075.

Most frequent study sections

  1. HIV Coinfections and HIV Associated Cancers Study Section[HCAC]2
  2. Drug Discovery and Mechanisms of Antimicrobial Resistance Study Section[DDR]1
  3. HIV Immunopathogenesis and Vaccine Development Study Section[HIVD]1
  4. Special Emphasis Panel[ZRG1 IDM-W (02)]1
  5. Virology - B Study Section[VIRB]1

Most frequent institutions

  1. JOHNS HOPKINS UNIVERSITY1
  2. MASSACHUSETTS GENERAL HOSPITAL1
  3. ROCKEFELLER UNIVERSITY1
  4. SAINT LOUIS UNIVERSITY1
  5. UNIVERSITY OF OXFORD1
Competing awards under PAS-19-097 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2020Human Genetic determinants of HBV recovery2R01AI148049-21A1DUGGAL, PRIYATHOMAS, DAVID LJOHNS HOPKINS UNIVERSITY, MD$788,585HCAC
2020Cooperative mechanisms of HIV-enhanced liver fibrogenesis in HBV Coinfection1R01AI155140-01CHUNG, RAYMOND TLIN, WENYUMASSACHUSETTS GENERAL HOSPITAL, MA$709,110HCAC
2020Launching HBV with RNA to assess antiviral resistance and explore fundamental aspects of virus-host biology1R01AI150275-01A1RICE, CHARLES MROCKEFELLER UNIVERSITY, NY$560,079ZRG1
2020Exploiting Natural Killer cells in HIV/HBV co-infection to achieve eradication1R01AI155182-01PEPPA, DIMITRAUNIVERSITY OF OXFORD$476,070HIVD
2020Autophagy and the Replication of Hepatitis B Virus1R01AI148304-01OU, J.-H. JAMESUNIVERSITY OF SOUTHERN CALIFORNIA, CA$412,500VIRB
2020HBV RNaseH inhibitors: Effects on HBV biology and resistance development1R01AI148362-01TAVIS, JOHN ESAINT LOUIS UNIVERSITY, MO$371,540DDR

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.